Skip to content

Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis

Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04475003
Enrollment
150
Registered
2020-07-17
Start date
2020-09-30
Completion date
2022-04-30
Last updated
2020-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaphylaxis, Health Literacy

Brief summary

Research on health literacy among caregivers of children with IgE-mediated allergy at risk of anaphylaxis (life-threatening allergic reaction). Health literacy is a person's ability to understand health information so that they can maintain or improve their health and quality of life (of themself and children). The aim of the study is to test the general knowledge of anaphylaxis. Furthermore we test the extent to which caregivers consider themselves able to recognize and to treat anaphylaxis.

Interventions

Teaching session about anaphylaxis

Sponsors

Algemeen Ziekenhuis Maria Middelares
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* caregivers of children with IgE-mediated allergy with risk of anaphylaxis (adults, grandparents, school caregivers etc.). * minimum 18 years old. * signed informed consent

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
General knowledge of anaphylaxis.1.5 yearKnowledge Quiz

Secondary

MeasureTime frameDescription
The extent to which caregivers consider themselves able to recognize and to treat anaphylaxis.1.5 yearNumeric scoring scale (0= cannot do at all, 5= highly certain can do)

Countries

Belgium

Contacts

Primary ContactJasmine S Leus
jasmine.leus@azmmsj.be+329 246 8200
Backup ContactJosefien L Vandekerckhove
josefien.vandekerckhove@gmail.com+329 246 8200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026